Skip to content

Blood Flow Restriction Training for The Shoulder

Blood Flow Restriction Training for The Shoulder: A Case for Proximal Benefit

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04540367
Enrollment
69
Registered
2020-09-07
Start date
2017-11-10
Completion date
2020-08-01
Last updated
2024-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

The aim of this study is to determine if BFR-LIX promotes greater increases in shoulder lean mass, rotator cuff strength, endurance, and acute increases in shoulder muscle activation compared to LIX alone.

Detailed description

Healthy Volunteers: Thirty-two healthy adults were randomized into two groups (BFRm=13,f=3, NoBFRm=10,f=6) that performed 8wks of shoulder LIX \[2/wk, 4 sets (30/15/15/fatigue), 20%max\] using common rotator cuff exercises \[cable external rotation (ER), cable internal rotation (IR), dumbbell scaption (SCAP), and side-lying dumbbell ER (SLER)\]. The BFR group also trained with an automated tourniquet placed at the proximal arm (50%-occlusion). Regional lean mass (dual-energy-xray-absorptiometry), isometric strength, and muscular endurance (repetitions-to-fatigue, RTF, 20%max, with and without 50%-occlusion) was measured before and after training. Electromyographic amplitude (EMGa) was also recorded from target shoulder muscles during endurance testing. A mixed-model ANCOVA (covaried on baseline measures) was used to detect within and between-group differences in primary outcome measures (α=0.05). Pitchers: Twenty-eight collegiate baseball pitchers were randomized into 2 groups (BFRN=15, NOBFRN=13) that, in conjunction with offseason training, performed 8wks of shoulder LIX \[Throwing arm only; 2/wk, 4 sets (30/15/15/fatigue), 20%isometric max\] using 4 exercises \[cable external and internal rotation (ER/IR), dumbbell scaption, and side-lying dumbbell ER\]. The BFR group also trained with an automated tourniquet on the proximal arm (50%-occlusion). Regional lean mass (dual-energy x-ray absorptiometry), rotator cuff strength (dynamometry: IR0&90, ° ER0&90, ° Scaption, Flexion), and fastball biomechanics were assessed pre- and post-training. Achievable workload (sets × reps × resistance) was also recorded. An ANCOVA (covaried on baseline measures) repeated on training timepoint was used to detect within-group and between-group differences in outcome measures (α=0.05). For significant pairwise comparisons, effect size (ES) was calculated using a Cohen's d statistic and interpreted as: 0-0.1, negligible(N); 0.1-0.3, small(S); 0.3-0.5, moderate(M); 0.5-0.7, large(L); \>0.7, very large(VL).

Interventions

DEVICEBlood flow restriction therapy

The study group underwent the same exercises as the control group modified by the use of a tourniquet for blood flow restriction during those exercises.

Sponsors

The Methodist Hospital Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Participants were randomized to either perform exercises with blood flow restriction therapy or without

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy, untrained volunteers

Exclusion criteria

1. Previous history of shoulder injury occurring in the laterality of choice 2. Current painful dysfunction resulting in exercise limitation 3. Any health-related exercise limitation as ordered by physician 4. Vascular compromise or previous vascular surgery 5. Ages outside of 18-65 6. Inability to access clinic and equipment 7. Currently involved in structured strength training regimen of the upper extremity

Design outcomes

Primary

MeasureTime frameDescription
Determine if BFR Changes UE Lean Muscle Mass in the General PopulationBaseline and 8 weeksUE lean muscle mass was measured in grams using DEXA. These data are reported as an average of both the left and right side.
Isometric Rotator Cuff Strength in General PopulationBaseline and 8 weeksPeak strength was measured using a hand-held dynamometer. A standardized procedure was used for shoulder strength testing, and all testing was performed by a sports-specialized (American Board of Physical Therapy Specialties Sports Clinical Specialist) physical therapist. A total of 6 different maximal isometric strength tests were used to measure the strength of the rotator cuff muscles in the following order: (1) seated forward flexion at 90 of shoulder abduction, (2) seated scaption at 90, (3) seated external rotation (ER) at 0, (4) seated internal rotation (IR) at 0, (5) prone ER at 90, and (6) prone IR at 90. Peak strength was measured using a microFET2 (Hoggan Scientific) hand-held dynamometer. For each isometric test, participants performed a 3-second maximal-exertion contraction against the dynamometer to determine peak strength. For each measure, tests were performed 3 times, and the highest value among the 3 trials was selected as the maximal strength value.
Determine if BFR Changes Shoulder Lean Muscle Mass in PitchersBaseline, 8 weeksShoulder lean muscle mass was measured in grams using DEXA. These data are reported for each arm.
Isometric Rotator Cuff Strength in PitchersBaseline, 8 weeksPeak strength was measured using a hand-held dynamometer. A standardized procedure was used for shoulder strength testing, and all testing was performed by a sports-specialized (American Board of Physical Therapy Specialties Sports Clinical Specialist) physical therapist. A total of 6 different maximal isometric strength tests were used to measure the strength of the rotator cuff muscles in the following order: (1) seated forward flexion at 90 of shoulder abduction, (2) seated scaption at 90, (3) seated external rotation (ER) at 0, (4) seated internal rotation (IR) at 0, (5) prone ER at 90, and (6) prone IR at 90. Peak strength was measured using a microFET2 (Hoggan Scientific) hand-held dynamometer. For each isometric test, participants performed a 3-second maximal-exertion contraction against the dynamometer to determine peak strength. For each measure, tests were performed 3 times, and the highest value among the 3 trials was selected as the maximal strength value.

Secondary

MeasureTime frameDescription
Strength Endurance in General PopulationBaseline and 8 weeksrepetitions to fatigue (RTF) were performed for 3 exercises. Volume (repetitions x resistance, kg) was calculated for each trial as is common for strength training investigations. After strength testing, participants were asked to perform the first of 2 endurance tests separated by 48 to 72 hours. On both occasions, a single set of repetitions to fatigue (RTF) were performed for 3 exercises in the following order: standing cable ER at 0 of shoulder abduction, standing cable IR at 0, and dumbbell scaption with each exercise separated by a 2-minute rest period and alternating between arms (order randomized). This test was performed in both groups with and without 50% limb occlusion pressure (LOP) applied by an automated tourniquet system. A nylon cuff was placed around the most proximal portion of the upper extremity for all testing. The order of testing was randomized between the 2 testing days for each participant.

Countries

United States

Participant flow

Participants by arm

ArmCount
No Intervention: Control (General Population)
Participants in this group performed the exercises without the blood flow restriction therapy cuff. Additionally, these participants are considered part of the general population.
16
Experimental: BFR (General Population)
Participants in this group performed the exercises with the blood flow restriction therapy cuff Blood flow restriction therapy: The study group underwent the same exercises as the control group modified by the use of a tourniquet for blood flow restriction during those exercises. Additionally, these participants are considered part of the general population.
16
No Intervention: Control (Pitchers)
Participants in this group performed the exercises without the blood flow restriction therapy cuff. Additionally, these participants are considered the pitchers.
13
Experimental: BFR (Pitchers)
Participants in this group performed the exercises with the blood flow restriction therapy cuff Blood flow restriction therapy: The study group underwent the same exercises as the control group modified by the use of a tourniquet for blood flow restriction during those exercises. Additionally, these participants are considered the pitchers.
15
Total60

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003
Overall StudyAdverse Event0011
Overall StudyCOVID-19 Contact Tracing Protocols prevented completion of study activities0041
Overall StudyWithdrawal by Subject0002

Baseline characteristics

CharacteristicTotalNo Intervention: Control (General Population)Experimental: BFR (General Population)No Intervention: Control (Pitchers)Experimental: BFR (Pitchers)
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
60 Participants16 Participants16 Participants13 Participants15 Participants
Age, Continuous26.7 years
STANDARD_DEVIATION 8.5
25.8 years
STANDARD_DEVIATION 8.3
27.6 years
STANDARD_DEVIATION 8.8
19.8 years
STANDARD_DEVIATION 1.5
19.7 years
STANDARD_DEVIATION 1.2
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
32 participants16 participants16 participants13 participants15 participants
Sex: Female, Male
Female
9 Participants6 Participants3 Participants0 Participants0 Participants
Sex: Female, Male
Male
51 Participants10 Participants13 Participants13 Participants15 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 160 / 160 / 130 / 15
other
Total, other adverse events
0 / 160 / 160 / 130 / 15
serious
Total, serious adverse events
0 / 161 / 160 / 130 / 15

Outcome results

Primary

Determine if BFR Changes Shoulder Lean Muscle Mass in Pitchers

Shoulder lean muscle mass was measured in grams using DEXA. These data are reported for each arm.

Time frame: Baseline, 8 weeks

ArmMeasureGroupValue (MEAN)Dispersion
General Population, No Intervention: ControlDetermine if BFR Changes Shoulder Lean Muscle Mass in PitchersShoulder Lean Muscle Mass in Throwing Arm at Baseline4291.8 gStandard Deviation 51.7
General Population, No Intervention: ControlDetermine if BFR Changes Shoulder Lean Muscle Mass in PitchersShoulder Lean Muscle Mass in Non-Throwing Arm at Baseline4284.1 gStandard Deviation 55.9
General Population, No Intervention: ControlDetermine if BFR Changes Shoulder Lean Muscle Mass in PitchersShoulder Lean Muscle Mass in Throwing Arm at 8 Weeks4307.3 gStandard Deviation 51.7
General Population, No Intervention: ControlDetermine if BFR Changes Shoulder Lean Muscle Mass in PitchersShoulder Lean Muscle Mass in Non-Throwing Arm at 8 Weeks4347.3 gStandard Deviation 56
General Population, Experimental: BFRDetermine if BFR Changes Shoulder Lean Muscle Mass in PitchersShoulder Lean Muscle Mass in Non-Throwing Arm at 8 Weeks4346.2 gStandard Deviation 55.5
General Population, Experimental: BFRDetermine if BFR Changes Shoulder Lean Muscle Mass in PitchersShoulder Lean Muscle Mass in Throwing Arm at Baseline4279 gStandard Deviation 52
General Population, Experimental: BFRDetermine if BFR Changes Shoulder Lean Muscle Mass in PitchersShoulder Lean Muscle Mass in Throwing Arm at 8 Weeks4410.1 gStandard Deviation 52
General Population, Experimental: BFRDetermine if BFR Changes Shoulder Lean Muscle Mass in PitchersShoulder Lean Muscle Mass in Non-Throwing Arm at Baseline4272.1 gStandard Deviation 55.5
Primary

Determine if BFR Changes UE Lean Muscle Mass in the General Population

UE lean muscle mass was measured in grams using DEXA. These data are reported as an average of both the left and right side.

Time frame: Baseline and 8 weeks

ArmMeasureGroupValue (MEAN)Dispersion
General Population, No Intervention: ControlDetermine if BFR Changes UE Lean Muscle Mass in the General PopulationUpper extremity lean muscle mass at 8 weeks-17 gStandard Deviation 77
General Population, No Intervention: ControlDetermine if BFR Changes UE Lean Muscle Mass in the General PopulationShoulder region lean muscle mass at 8 weeks96 gStandard Deviation 61
General Population, Experimental: BFRDetermine if BFR Changes UE Lean Muscle Mass in the General PopulationUpper extremity lean muscle mass at 8 weeks175 gStandard Deviation 54
General Population, Experimental: BFRDetermine if BFR Changes UE Lean Muscle Mass in the General PopulationShoulder region lean muscle mass at 8 weeks278 gStandard Deviation 90
Primary

Isometric Rotator Cuff Strength in General Population

Peak strength was measured using a hand-held dynamometer. A standardized procedure was used for shoulder strength testing, and all testing was performed by a sports-specialized (American Board of Physical Therapy Specialties Sports Clinical Specialist) physical therapist. A total of 6 different maximal isometric strength tests were used to measure the strength of the rotator cuff muscles in the following order: (1) seated forward flexion at 90 of shoulder abduction, (2) seated scaption at 90, (3) seated external rotation (ER) at 0, (4) seated internal rotation (IR) at 0, (5) prone ER at 90, and (6) prone IR at 90. Peak strength was measured using a microFET2 (Hoggan Scientific) hand-held dynamometer. For each isometric test, participants performed a 3-second maximal-exertion contraction against the dynamometer to determine peak strength. For each measure, tests were performed 3 times, and the highest value among the 3 trials was selected as the maximal strength value.

Time frame: Baseline and 8 weeks

ArmMeasureGroupValue (MEAN)Dispersion
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in General PopulationPre IR at 020.1 kgStandard Deviation 0.7
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in General PopulationPost Flexion11.9 kgStandard Deviation 0.4
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in General PopulationPost IR at 020.2 kgStandard Deviation 0.7
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in General PopulationPost Scaption12.5 kgStandard Deviation 0.2
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in General PopulationPre ER at 9015.6 kgStandard Deviation 0.7
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in General PopulationPre Flexion12.1 kgStandard Deviation 0.4
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in General PopulationPost ER at 9014.7 kgStandard Deviation 0.8
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in General PopulationPre ER at 013.7 kgStandard Deviation 0.4
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in General PopulationPre IR at 9017.4 kgStandard Deviation 0.8
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in General PopulationPre Scaption12 kgStandard Deviation 0.2
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in General PopulationPost IR at 9018.1 kgStandard Deviation 0.8
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in General PopulationPost ER at 013.9 kgStandard Deviation 0.4
General Population, Experimental: BFRIsometric Rotator Cuff Strength in General PopulationPost IR at 9018.6 kgStandard Deviation 0.8
General Population, Experimental: BFRIsometric Rotator Cuff Strength in General PopulationPre Flexion12.2 kgStandard Deviation 0.4
General Population, Experimental: BFRIsometric Rotator Cuff Strength in General PopulationPost Flexion12.8 kgStandard Deviation 0.4
General Population, Experimental: BFRIsometric Rotator Cuff Strength in General PopulationPre Scaption12.1 kgStandard Deviation 0.2
General Population, Experimental: BFRIsometric Rotator Cuff Strength in General PopulationPost Scaption12.4 kgStandard Deviation 0.2
General Population, Experimental: BFRIsometric Rotator Cuff Strength in General PopulationPre ER at 013.9 kgStandard Deviation 0.4
General Population, Experimental: BFRIsometric Rotator Cuff Strength in General PopulationPre IR at 020.2 kgStandard Deviation 0.7
General Population, Experimental: BFRIsometric Rotator Cuff Strength in General PopulationPost IR at 023.1 kgStandard Deviation 0.7
General Population, Experimental: BFRIsometric Rotator Cuff Strength in General PopulationPre ER at 9016 kgStandard Deviation 0.7
General Population, Experimental: BFRIsometric Rotator Cuff Strength in General PopulationPost ER at 9016.1 kgStandard Deviation 0.7
General Population, Experimental: BFRIsometric Rotator Cuff Strength in General PopulationPre IR at 9017.9 kgStandard Deviation 0.8
General Population, Experimental: BFRIsometric Rotator Cuff Strength in General PopulationPost ER at 014.1 kgStandard Deviation 0.4
Primary

Isometric Rotator Cuff Strength in Pitchers

Peak strength was measured using a hand-held dynamometer. A standardized procedure was used for shoulder strength testing, and all testing was performed by a sports-specialized (American Board of Physical Therapy Specialties Sports Clinical Specialist) physical therapist. A total of 6 different maximal isometric strength tests were used to measure the strength of the rotator cuff muscles in the following order: (1) seated forward flexion at 90 of shoulder abduction, (2) seated scaption at 90, (3) seated external rotation (ER) at 0, (4) seated internal rotation (IR) at 0, (5) prone ER at 90, and (6) prone IR at 90. Peak strength was measured using a microFET2 (Hoggan Scientific) hand-held dynamometer. For each isometric test, participants performed a 3-second maximal-exertion contraction against the dynamometer to determine peak strength. For each measure, tests were performed 3 times, and the highest value among the 3 trials was selected as the maximal strength value.

Time frame: Baseline, 8 weeks

ArmMeasureGroupValue (MEAN)Dispersion
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in PitchersPre Flexion in Non-throwing arm14.7 kgStandard Deviation 0.6
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in PitchersPre IR at 0 in Throwing Arm24.8 kgStandard Deviation 1.4
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in PitchersPre Scaption in Non-Throwing Arm14.7 kgStandard Deviation 0.6
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in PitchersPost IR at 0 in Throwing Arm21.8 kgStandard Deviation 1.4
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in PitchersPre IR at 0 in Non-Throwing Arm24.2 kgStandard Deviation 1.3
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in PitchersPost Scaption in Non-Throwing Arm14.1 kgStandard Deviation 0.6
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in PitchersPost IR at 0 in Non-Throwing Arm22.5 kgStandard Deviation 1.3
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in PitchersPost Flexion in Throwing Arm13.2 kgStandard Deviation 0.6
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in PitchersPre ER at 90 in Throwing Arm19.7 kgStandard Deviation 1.4
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in PitchersPre ER at 0 in Throwing Arm16.2 kgStandard Deviation 0.9
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in PitchersPost ER at 90 in Throwing Arm18.9 kgStandard Deviation 1.4
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in PitchersPre Scaption in Throwing Arm14.7 kgStandard Deviation 0.6
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in PitchersPre ER at 90 in Non-Throwing Arm20.1 kgStandard Deviation 1.4
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in PitchersPost ER at 0 in Throwing Arm16.4 kgStandard Deviation 0.9
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in PitchersPost ER at 90 in Non-Throwing Arm21.1 kgStandard Deviation 1.4
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in PitchersPre Flexion in Throwing Arm14.8 kgStandard Deviation 0.6
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in PitchersPre IR at 90 in Throwing Arm20.0 kgStandard Deviation 1.5
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in PitchersPre ER at 0 in Non-Throwing Arm16.0 kgStandard Deviation 0.9
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in PitchersPost IR at 90 in Throwing Arm20.9 kgStandard Deviation 1.5
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in PitchersPost Scaption in Throwing Arm14.5 kgStandard Deviation 0.6
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in PitchersPre IR at 90 in Non-Throwing Arm19.5 kgStandard Deviation 1.5
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in PitchersPost ER at 0 in Non-Throwing Arm16.0 kgStandard Deviation 0.9
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in PitchersPost IR at 90 in Non-Throwing Arm21.4 kgStandard Deviation 1.5
General Population, No Intervention: ControlIsometric Rotator Cuff Strength in PitchersPost flexion in Non-Throwing Arm14.2 kgStandard Deviation 0.6
General Population, Experimental: BFRIsometric Rotator Cuff Strength in PitchersPost IR at 90 in Non-Throwing Arm20.4 kgStandard Deviation 1.4
General Population, Experimental: BFRIsometric Rotator Cuff Strength in PitchersPre Flexion in Throwing Arm14.7 kgStandard Deviation 0.5
General Population, Experimental: BFRIsometric Rotator Cuff Strength in PitchersPost Flexion in Throwing Arm14.0 kgStandard Deviation 0.5
General Population, Experimental: BFRIsometric Rotator Cuff Strength in PitchersPre Flexion in Non-throwing arm14.6 kgStandard Deviation 0.5
General Population, Experimental: BFRIsometric Rotator Cuff Strength in PitchersPost flexion in Non-Throwing Arm14.0 kgStandard Deviation 0.5
General Population, Experimental: BFRIsometric Rotator Cuff Strength in PitchersPre Scaption in Throwing Arm14.7 kgStandard Deviation 0.5
General Population, Experimental: BFRIsometric Rotator Cuff Strength in PitchersPost Scaption in Throwing Arm14.5 kgStandard Deviation 0.5
General Population, Experimental: BFRIsometric Rotator Cuff Strength in PitchersPre Scaption in Non-Throwing Arm14.7 kgStandard Deviation 0.5
General Population, Experimental: BFRIsometric Rotator Cuff Strength in PitchersPost Scaption in Non-Throwing Arm14.3 kgStandard Deviation 0.5
General Population, Experimental: BFRIsometric Rotator Cuff Strength in PitchersPre ER at 0 in Throwing Arm15.9 kgStandard Deviation 0.8
General Population, Experimental: BFRIsometric Rotator Cuff Strength in PitchersPost ER at 0 in Throwing Arm15.8 kgStandard Deviation 0.8
General Population, Experimental: BFRIsometric Rotator Cuff Strength in PitchersPre ER at 0 in Non-Throwing Arm16.0 kgStandard Deviation 0.8
General Population, Experimental: BFRIsometric Rotator Cuff Strength in PitchersPost ER at 0 in Non-Throwing Arm15.9 kgStandard Deviation 0.8
General Population, Experimental: BFRIsometric Rotator Cuff Strength in PitchersPre IR at 0 in Throwing Arm24.3 kgStandard Deviation 1.2
General Population, Experimental: BFRIsometric Rotator Cuff Strength in PitchersPost IR at 0 in Throwing Arm25.4 kgStandard Deviation 1.2
General Population, Experimental: BFRIsometric Rotator Cuff Strength in PitchersPre IR at 0 in Non-Throwing Arm24.1 kgStandard Deviation 1.2
General Population, Experimental: BFRIsometric Rotator Cuff Strength in PitchersPost IR at 0 in Non-Throwing Arm24.4 kgStandard Deviation 1.2
General Population, Experimental: BFRIsometric Rotator Cuff Strength in PitchersPre ER at 90 in Throwing Arm19.7 kgStandard Deviation 1.3
General Population, Experimental: BFRIsometric Rotator Cuff Strength in PitchersPost ER at 90 in Throwing Arm17.3 kgStandard Deviation 1.3
General Population, Experimental: BFRIsometric Rotator Cuff Strength in PitchersPre ER at 90 in Non-Throwing Arm20.0 kgStandard Deviation 1.3
General Population, Experimental: BFRIsometric Rotator Cuff Strength in PitchersPost ER at 90 in Non-Throwing Arm17.8 kgStandard Deviation 1.3
General Population, Experimental: BFRIsometric Rotator Cuff Strength in PitchersPre IR at 90 in Throwing Arm19.7 kgStandard Deviation 1.3
General Population, Experimental: BFRIsometric Rotator Cuff Strength in PitchersPost IR at 90 in Throwing Arm22.1 kgStandard Deviation 1.3
General Population, Experimental: BFRIsometric Rotator Cuff Strength in PitchersPre IR at 90 in Non-Throwing Arm19.9 kgStandard Deviation 1.4
Secondary

Strength Endurance in General Population

repetitions to fatigue (RTF) were performed for 3 exercises. Volume (repetitions x resistance, kg) was calculated for each trial as is common for strength training investigations. After strength testing, participants were asked to perform the first of 2 endurance tests separated by 48 to 72 hours. On both occasions, a single set of repetitions to fatigue (RTF) were performed for 3 exercises in the following order: standing cable ER at 0 of shoulder abduction, standing cable IR at 0, and dumbbell scaption with each exercise separated by a 2-minute rest period and alternating between arms (order randomized). This test was performed in both groups with and without 50% limb occlusion pressure (LOP) applied by an automated tourniquet system. A nylon cuff was placed around the most proximal portion of the upper extremity for all testing. The order of testing was randomized between the 2 testing days for each participant.

Time frame: Baseline and 8 weeks

ArmMeasureGroupValue (MEAN)Dispersion
General Population, No Intervention: ControlStrength Endurance in General PopulationCable ER - Pre at 50% LOP97.3 kgStandard Deviation 10.8
General Population, No Intervention: ControlStrength Endurance in General PopulationCable ER Post at 50% LOP155.1 kgStandard Deviation 10.8
General Population, No Intervention: ControlStrength Endurance in General PopulationCable IR - Pre at 50% LOP230.7 kgStandard Deviation 19.5
General Population, No Intervention: ControlStrength Endurance in General PopulationCable IR - Post at 50% LOP305.9 kgStandard Deviation 19.5
General Population, No Intervention: ControlStrength Endurance in General PopulationScaption - Pre at 50% LOP134.8 kgStandard Deviation 18.8
General Population, No Intervention: ControlStrength Endurance in General PopulationScaption - Post at 50% LOP211.2 kgStandard Deviation 18.8
General Population, No Intervention: ControlStrength Endurance in General PopulationCable ER - Pre without LOP99.5 kgStandard Deviation 12.8
General Population, No Intervention: ControlStrength Endurance in General PopulationCable ER Post without LOP157.2 kgStandard Deviation 10.7
General Population, No Intervention: ControlStrength Endurance in General PopulationCable IR - Pre at without LOP249.1 kgStandard Deviation 17.8
General Population, No Intervention: ControlStrength Endurance in General PopulationCable IR - Post at without LOP342.2 kgStandard Deviation 17.8
General Population, No Intervention: ControlStrength Endurance in General PopulationScaption - Pre at without LOP138.6 kgStandard Deviation 18.3
General Population, No Intervention: ControlStrength Endurance in General PopulationScaption - Post without LOP222.7 kgStandard Deviation 18.4
General Population, Experimental: BFRStrength Endurance in General PopulationScaption - Pre at without LOP140.2 kgStandard Deviation 18.4
General Population, Experimental: BFRStrength Endurance in General PopulationCable ER - Pre at 50% LOP94.1 kgStandard Deviation 10.9
General Population, Experimental: BFRStrength Endurance in General PopulationCable ER - Pre without LOP96.2 kgStandard Deviation 10.8
General Population, Experimental: BFRStrength Endurance in General PopulationCable ER Post at 50% LOP155.1 kgStandard Deviation 10.9
General Population, Experimental: BFRStrength Endurance in General PopulationCable IR - Post at without LOP407 kgStandard Deviation 17.9
General Population, Experimental: BFRStrength Endurance in General PopulationCable IR - Pre at 50% LOP230.9 kgStandard Deviation 19.5
General Population, Experimental: BFRStrength Endurance in General PopulationCable ER Post without LOP155.9 kgStandard Deviation 10.8
General Population, Experimental: BFRStrength Endurance in General PopulationCable IR - Post at 50% LOP389.5 kgStandard Deviation 19.6
General Population, Experimental: BFRStrength Endurance in General PopulationScaption - Post without LOP231.7 kgStandard Deviation 18.4
General Population, Experimental: BFRStrength Endurance in General PopulationScaption - Pre at 50% LOP137 kgStandard Deviation 18.9
General Population, Experimental: BFRStrength Endurance in General PopulationCable IR - Pre at without LOP249.3 kgStandard Deviation 17.9
General Population, Experimental: BFRStrength Endurance in General PopulationScaption - Post at 50% LOP240.3 kgStandard Deviation 18.8

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026